THE BEST SIDE OF PSILOCIN

) [153]. this technique is presently not scalable because it depends on high-priced startup substrates which can be utilized to generate psilocybin in cheaper chemical synthesis methodologies. A methodology for de novo manufacture of psilocybin and tryptamine derivatives in Saccharomyces cerevisiae, is named soon after Dr. Andrew Weil, a renowned